Tanvex BioPharma Statistics

Total Valuation

TPE:6541 has a market cap or net worth of TWD 15.08 billion. The enterprise value is 16.35 billion.

Market Cap	15.08B
Enterprise Value	16.35B

Important Dates

The last earnings date was Friday, March 7, 2025.

Earnings Date	Mar 7, 2025
Ex-Dividend Date	n/a

Share Statistics

TPE:6541 has 238.16 million shares outstanding. The number of shares has increased by 20.44% in one year.

Current Share Class	n/a
Shares Outstanding	238.16M
Shares Change (YoY)	+20.44%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.95%
Owned by Institutions (%)	2.02%
Float	100.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	283.38
PB Ratio	11.63
P/TBV Ratio	17.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-11.83
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.01

Financial Position

The company has a current ratio of 1.94, with a Debt / Equity ratio of 1.85.

Current Ratio	1.94
Quick Ratio	1.17
Debt / Equity	1.85
Debt / EBITDA	n/a
Debt / FCF	-1.31
Interest Coverage	-25.43

Financial Efficiency

Return on equity (ROE) is -161.17% and return on invested capital (ROIC) is -33.29%.

Return on Equity (ROE)	-161.17%
Return on Assets (ROA)	-30.84%
Return on Invested Capital (ROIC)	-33.29%
Return on Capital Employed (ROCE)	-56.84%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.01
Inventory Turnover	0.16

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.53% in the last 52 weeks. The beta is 0.19, so TPE:6541's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	+28.53%
50-Day Moving Average	70.69
200-Day Moving Average	63.84
Relative Strength Index (RSI)	30.46
Average Volume (20 Days)	380,850

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPE:6541 had revenue of TWD 34.68 million and -1.38 billion in losses. Loss per share was -8.90.

Revenue	34.68M
Gross Profit	8.29M
Operating Income	-1.36B
Pretax Income	-1.38B
Net Income	-1.38B
EBITDA	-1.25B
EBIT	-1.36B
Loss Per Share	-8.90

Full Income Statement

Balance Sheet

The company has 376.96 million in cash and 1.65 billion in debt, giving a net cash position of -1.27 billion or -5.34 per share.

Cash & Cash Equivalents	376.96M
Total Debt	1.65B
Net Cash	-1.27B
Net Cash Per Share	-5.34
Equity (Book Value)	893.31M
Book Value Per Share	5.44
Working Capital	327.48M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.15 billion and capital expenditures -105.91 million, giving a free cash flow of -1.26 billion.

Operating Cash Flow	-1.15B
Capital Expenditures	-105.91M
Free Cash Flow	-1.26B
FCF Per Share	-5.28

Full Cash Flow Statement

Margins

Gross Margin	23.91%
Operating Margin	-3,912.40%
Pretax Margin	-3,982.94%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPE:6541 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.44%
Shareholder Yield	-20.44%
Earnings Yield	-9.16%
FCF Yield	-8.33%

Stock Splits

The last stock split was on March 2, 2023. It was a reverse split with a ratio of 0.3335779572.

Last Split Date	Mar 2, 2023
Split Type	Reverse
Split Ratio	0.3335779572

Scores

TPE:6541 has an Altman Z-Score of -5.72. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.72
Piotroski F-Score	n/a